UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?

British journal of cancer, 2013-09, Vol.109 (5), p.1338-1343

2013

Volltextzugriff (PDF)

2163 BRAF testing in the community setting; are we testing enough given the importance of BRAF mutation and the clinical implications?

European journal of cancer (1990), 2015-09, Vol.51, p.S388-S388

2015

Volltextzugriff (PDF)

6040 POSTER Liver Only Metastatic Disease in Patients With Metastatic Colorectal Cancer (mCRC), Impact of Surgery and Chemotherapy

European journal of cancer (1990), 2011, Vol.47, p.S403-S403

2011

Volltextzugriff (PDF)

514PDOES EXACT PRIMARY SITE IMPACT ON OUTCOME FOR METASTATIC COLORECTAL CANCER (MCRC)?

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv174-iv174

2014

Volltextzugriff (PDF)

Does Exact Primary Site Impact on Outcome for Metastatic Colorectal Cancer (Mcrc)?

Annals of oncology, 2014-09, Vol.25, p.iv174

2014

Volltextzugriff (PDF)

Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry

The Australian journal of rural health, 2016-04, Vol.24 (2), p.85-91

2016

Volltextzugriff (PDF)

Impact of watching prior to commencement of chemotherapy for metastatic colorectal cancer (mCRC): Findings from the South Australian Clinical Registry (SACR) for mCRC

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14139-e14139

2011

Volltextzugriff (PDF)

Rechallenge with oxaliplatin and fluoropyrimidine (FOX) after prior therapy in metastatic colorectal carcinoma (mCRC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14118-e14118

2011

Volltextzugriff (PDF)

A population-based study of metastatic colorectal cancer (mCRC) in people age 80 or older: Findings from the South Australian Clinical Registry (SACR) for mCRC

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.9082-9082

2011

Volltextzugriff (PDF)

An analysis of the effect of stage at diagnosis of bowel cancer on survival: Findings from the South Australian Clinical Registry (SACR) for metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3628-3628

2011

Volltextzugriff (PDF)

A population-based study of metastatic colorectal cancer (mCRC) in people age 80 and older: Findings from the South Australian Clinical Registry (SACR) for mCRC

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.514-514

2011

Volltextzugriff (PDF)

Dérivation nominale et innovations dans les langues indo‑européennes anciennes

2021

Volltextzugriff (PDF)

Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding

Nature genetics, 2018-04, Vol.50 (4), p.498-503

2018

Volltextzugriff (PDF)

Conflits et violences dans le bassin du lac Tchad: Actes du XVIIe colloque Méga-Tchad

2020

Volltextzugriff (PDF)

Principles and philosophies for speech and language therapists working with people with primary progressive aphasia: an international expert consensus

Disability and rehabilitation, 2023-03, Vol.45 (6), p.1063-1078

2023

Volltextzugriff (PDF)

Better conversations: a language and communication intervention for aphasia in posterior cortical atrophy

Neurocase, 2022-08, Vol.28 (4), p.356-363

2022

Volltextzugriff (PDF)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection

The New England journal of medicine, 2022-03, Vol.386 (13), p.1207-1220

2022

Volltextzugriff (PDF)

Maternal and paternal lineages in cross-breeding bovine species. Has wisent a hybrid origin?

Molecular biology and evolution, 2004-07, Vol.21 (7), p.1165-1170

2004

Volltextzugriff (PDF)

Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin

Nature communications, 2015-05, Vol.6 (1), p.7085-7085, Article 7085

2015

Volltextzugriff (PDF)

Invaluable Benefits of 10 Years of the International Collaboration of Aphasia Trialists (CATs)

Stroke (1970), 2024-04, Vol.55 (4), p.1129

2024

Volltextzugriff (PDF)

"I don't know": a usage-based approach to familiar collocations in non-fluent aphasia

Aphasiology, 2019-02, Vol.33 (2), p.140-162

2019

Volltextzugriff (PDF)

Investigating Zeta Globin Gene Expression to Develop a Potential Therapy for Alpha Thalassemia Major

Blood, 2020-11, Vol.136 (Supplement 1), p.3-4

2020

Volltextzugriff (PDF)

Training flexibility in fixed expressions in non‐fluent aphasia: A case series report

International journal of language & communication disorders, 2021-09, Vol.56 (5), p.1009-1025

2021

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?

2163 BRAF testing in the community setting; are we testing enough given the importance of BRAF mutation and the clinical implications?

6040 POSTER Liver Only Metastatic Disease in Patients With Metastatic Colorectal Cancer (mCRC), Impact of Surgery and Chemotherapy

514PDOES EXACT PRIMARY SITE IMPACT ON OUTCOME FOR METASTATIC COLORECTAL CANCER (MCRC)?

Does Exact Primary Site Impact on Outcome for Metastatic Colorectal Cancer (Mcrc)?

Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry

Impact of watching prior to commencement of chemotherapy for metastatic colorectal cancer (mCRC): Findings from the South Australian Clinical Registry (SACR) for mCRC

Rechallenge with oxaliplatin and fluoropyrimidine (FOX) after prior therapy in metastatic colorectal carcinoma (mCRC)

A population-based study of metastatic colorectal cancer (mCRC) in people age 80 or older: Findings from the South Australian Clinical Registry (SACR) for mCRC

An analysis of the effect of stage at diagnosis of bowel cancer on survival: Findings from the South Australian Clinical Registry (SACR) for metastatic colorectal cancer (mCRC)

A population-based study of metastatic colorectal cancer (mCRC) in people age 80 and older: Findings from the South Australian Clinical Registry (SACR) for mCRC

Dérivation nominale et innovations dans les langues indo‑européennes anciennes

Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding

Conflits et violences dans le bassin du lac Tchad: Actes du XVIIe colloque Méga-Tchad

Principles and philosophies for speech and language therapists working with people with primary progressive aphasia: an international expert consensus

Better conversations: a language and communication intervention for aphasia in posterior cortical atrophy

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection

Maternal and paternal lineages in cross-breeding bovine species. Has wisent a hybrid origin?

Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin

Invaluable Benefits of 10 Years of the International Collaboration of Aphasia Trialists (CATs)

"I don't know": a usage-based approach to familiar collocations in non-fluent aphasia

Investigating Zeta Globin Gene Expression to Develop a Potential Therapy for Alpha Thalassemia Major

Training flexibility in fixed expressions in non‐fluent aphasia: A case series report

Consensus molecular subtypes (CMS) as prognostic and predictive biomarkers of panitumumab (Pmab), fluorouracil and folinic acid (FU/FA) or FU/FA maintenance therapy following Pmab-FOLFOX induction in RAS wildtype metastatic colorectal cancer (mCRC): PANAMA trial (AIO-KRK-0212)

Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC): Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab)

Suchergebnisse filtern